Should chemotherapy still be used to treat all muscle invasive bladder cancer in the "era of immunotherapy"?

Expert Rev Anticancer Ther. 2019 Jul;19(7):543-545. doi: 10.1080/14737140.2019.1625773. Epub 2019 Jun 5.

Authors

Jonathan J Duplisea¹, Colin P N Dinney¹

Affiliation

¹ a Department of Urology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

PMID: 31164019
DOI: 10.1080/14737140.2019.1625773

No abstract available

Keywords: Muscle invasive bladder cancer; chemotherapy; immunotherapy.

Publication types

Editorial

MeSH terms

Antineoplastic Agents / administration & dosage*
Cisplatin / administration & dosage
Humans
Immunotherapy / methods*
Neoplasm Invasiveness
Urinary Bladder Neoplasms / pathology
Urinary Bladder Neoplasms / therapy*

Substances

Antineoplastic Agents
Cisplatin